Crystallization Process Development for the Final Step of the Biocatalytic Synthesis of Islatravir: Comprehensive Crystal Engineering for a Low-Dose Drug
- 22 January 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (2) , 308-317
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Islatravir Case Study for Enhanced Screening of Thermodynamically Stable Crystalline Anhydrate Phases in Pharmaceutical Process Development by Hot Melt ExtrusionMolecular Pharmaceutics, 2020
- Design of an in vitro biocatalytic cascade for the manufacture of islatravirScience, 2019
- When Crystals Do Not Grow: The Growth Dead ZoneCrystal Growth & Design, 2019
- Engineering of acetaminophen particle attributes using a wet milling crystallisation platformInternational Journal of Pharmaceutics, 2019
- Improving the Filterability of Particles by Healing the Seed ParticlesOrganic Process Research & Development, 2018
- Development of New Laboratory Tools for Assessment of Granulation Behavior During Bulk Active Pharmaceutical Ingredient DryingJournal of Pharmaceutical Sciences, 2014
- Lean Filtration: Approaches for the Estimation of Cake PropertiesOrganic Process Research & Development, 2011
- Generation of Fine Pharmaceutical Particles via Controlled Secondary Nucleation under High Shear Environment during Crystallization − Process Development and Scale-upOrganic Process Research & Development, 2007
- Particle Size Limits to Meet USP Content Uniformity Criteria for Tablets and CapsulesJournal of Pharmaceutical Sciences, 2006
- Non-linear van't Hoff solubility-temperature plots and their pharmaceutical interpretationInternational Journal of Pharmaceutics, 1984